Cargando…

Retrospective Evaluation of Rabbit Antithymocyte Globulin Induction in Heart Transplant Patients

The dosing intensity of antithymocyte globulin as induction therapy in heart transplantation remains controversial. We sought to evaluate the efficacy and safety of rabbit antithymocyte globulin at a total dose of 4.5 mg/kg compared with <4.5 mg/kg. METHODS. This was a retrospective study of cons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Grace Pui-Yun, Cheng, Richard K., Vasbinder, Alexi, Wu, Sixuan, Wong, Beatrice, Farris, Stephen D., Fishbein, Daniel, Wong, Jenny Man-Ching
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Heart Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148697/ https://www.ncbi.nlm.nih.gov/pubmed/35651585 http://dx.doi.org/10.1097/TXD.0000000000001329

Ejemplares similares

Tailored Rabbit Antithymocyte Globulin Induction Dosing for Kidney Transplantation
por: Singh, Namita, et al.
Publicado: (2018)

Antithymocyte globulin exposure in CD34(+) T-cell–depleted allogeneic hematopoietic cell transplantation
por: Lakkaraja, Madhavi, et al.
Publicado: (2022)

Reassessing Rabbit Antithymocyte Globulin Induction in Kidney Transplantation (RETHINK): An Analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Registry
por: Ashoor, Isa F., et al.
Publicado: (2020)

Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study
por: Lam, Ngan N., et al.
Publicado: (2021)

A Review of Induction with Rabbit Antithymocyte Globulin in Pediatric Heart Transplant Recipients
por: Schweiger, Martin, et al.
Publicado: (2018)

Rabbit Antithymocyte Globulin Induction in Heart Transplant Recipients at High Risk for Rejection
por: Kitto, Brent, et al.
Publicado: (2021)

Poor Patient and Graft Outcome After Induction Treatment by Antithymocyte Globulin in Recipients of a Kidney Graft After Nonrenal Organ Transplantation
por: Mai, Hoa Le, et al.
Publicado: (2018)

Induction with Rabbit Antithymocyte Globulin following Orthotopic Liver Transplantation for Hepatitis C
por: Saidi, R. F., et al.
Publicado: (2011)

Timing of rabbit antithymocyte globulin induction therapy in kidney transplantation: an observational cohort study
por: Harrison, Jennifer J, et al.
Publicado: (2014)

Rabbit Antithymocyte Globulin Causes Blastomyces and Histoplasma Antigenemia
por: Kaur, Amrit, et al.
Publicado: (2019)

Reversibility of Frailty After Bridge-to-Transplant Ventricular Assist Device Implantation or Heart Transplantation
por: Jha, Sunita R., et al.
Publicado: (2017)

Rejection-associated Mitochondrial Impairment After Heart Transplantation
por: Romero, Erick, et al.
Publicado: (2020)

Clinical Outcomes of Perioperative Desensitization in Heart Transplant Recipients
por: Plazak, Michael E., et al.
Publicado: (2021)

Factors Associated With Sinoatrial Reinnervation After Heart Transplantation
por: Christensen, Anders H., et al.
Publicado: (2023)

Access to Heart Transplantation: A Proper Analysis of the Competing Risks of Death and Transplantation Is Required to Optimize Graft Allocation
por: Cantrelle, Christelle, et al.
Publicado: (2017)

Ex Situ Perfusion of Hearts Donated After Euthanasia: A Promising Contribution to Heart Transplantation
por: van Suylen, Vincent, et al.
Publicado: (2021)

Efficacy and Safety of Empagliflozin in the Management of Diabetes Mellitus in Heart Transplant Recipients
por: Cehic, Matthew G., et al.
Publicado: (2019)

De Novo Belatacept in a Kidney-After-Heart Transplant Recipient
por: Schenk, Austin D., et al.
Publicado: (2019)

Impact of New UNOS Allocation Criteria on Heart Transplant Practices and Outcomes
por: Liu, Jason, et al.
Publicado: (2020)

Pulmonary Function Testing Pre–heart Transplant Predicts Posttransplant Survival
por: Lundgren, Scott W., et al.
Publicado: (2021)

Biomarkers to Assess Right Heart Pressures in Recipients of a Heart Transplant: A Proof-of-Concept Study
por: Huang, Qi-Fang, et al.
Publicado: (2018)

Impact of Heart Transplantation on the Recovery of Peripheral and Respiratory Muscle Mass and Strength in Patients With Chronic Heart Failure
por: Fernandes, Lenise C. B. C., et al.
Publicado: (2018)

Simultaneous Versus Sequential Heart-liver Transplantation: Ideal Strategies for Organ Allocation
por: Rucker, A. Justin, et al.
Publicado: (2018)

Trends in Heart and Lung Transplantation in the United States Across the COVID-19 Pandemic
por: Hallett, Andrew, et al.
Publicado: (2021)

Veno-arterial Extracorporeal Membrane Oxygenation as Bridge to Heart Transplantation: The Way Forward
por: Montisci, Andrea, et al.
Publicado: (2021)

Value of Renal Histology in Predicting Cardiorenal Outcomes in Heart Transplant–listed Patients
por: Barua, Sumita, et al.
Publicado: (2022)

Influence of Tricuspid Regurgitation After Heart Transplantation: A Single-center Experience
por: Krey, Rebecca, et al.
Publicado: (2023)

Patient and Caregiver Health-related Quality of Life and Caregiver Burden While Awaiting Heart Transplantation: Findings From the Sustaining Quality of Life of the Aged: Heart Transplant or Mechanical Support (SUSTAIN-IT) Study
por: Grady, Kathleen L., et al.
Publicado: (2021)

Hemodynamic Response to Acute Volume Load and Endomyocardial NO-synthase Gene Expression in Heart Transplant Recipients
por: Kobediona, Monika, et al.
Publicado: (2022)

Coronary Collateral Circulation: A New Predictor of Mortality in Heart Transplant Recipients With Allograft Vasculopathy
por: Civieri, Giovanni, et al.
Publicado: (2023)

Disseminated Intravascular Coagulation Following Heart Transplant in an HIV-infected Recipient: Case Report and Review of the Literature
por: Zhou, Xun, et al.
Publicado: (2019)

Three-Dimensional Self-Navigated T2 Mapping for the Detection of Acute Cellular Rejection After Orthotopic Heart Transplantation
por: van Heeswijk, Ruud B., et al.
Publicado: (2017)

Ex Vivo Heart Perfusion for Cardiac Transplantation Allowing for Prolonged Perfusion Time and Extension of Distance Traveled for Procurement of Donor Hearts: An Initial Experience in the United States
por: Isath, Ameesh, et al.
Publicado: (2023)

Low MicroRNA-126 Levels in Right Ventricular Endomyocardial Biopsies Coincide With Cardiac Allograft Vasculopathy in Heart Transplant Patients
por: Heggermont, Ward A., et al.
Publicado: (2020)

Heart Transplantation From Hepatitis C–Positive Donors in the Era of Direct Acting Antiviral Therapy: A Comprehensive Literature Review
por: Bruno, Schnegg, et al.
Publicado: (2019)

Mitochondrial Damage-associated Molecular Patterns as Potential Biomarkers in DCD Heart Transplantation: Lessons From Myocardial Infarction and Cardiac Arrest
por: Longnus, Sarah L., et al.
Publicado: (2021)

Heart Transplantation, Either Alone or Combined With Liver and Kidney, a Viable Treatment Option for Selected Patients With Severe Cardiac Amyloidosis
por: Guendouz, Soulef, et al.
Publicado: (2022)

Sex Related Differences in the Risk of Antibody-Mediated Rejection and Subsequent Allograft Vasculopathy Post-Heart Transplantation: A Single-Center Experience
por: Grupper, Avishay, et al.
Publicado: (2016)

The Interaction of Amiodarone and Continuous-flow Left Ventricular Assist Device Use in Risk of Severe Primary Graft Dysfunction Following Heart Transplantation
por: Chinnadurai, Thiru, et al.
Publicado: (2022)

Analysis of Fibrotic Plaques in Angiographic Manifest Cardiac Allograft Vasculopathy in Long-term Heart Transplanted Patients Using Optical Coherence Tomography
por: Orban, Madeleine, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1b7dfuvrkmvsa94t37v5tclaj8